Belgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the company’s early-stage investors Heran Partners, BTOV and PMV.
Hospitals have been digitised for a while now and have an enormous amount of data at their disposal to develop better patient care and scientific research. However, an estimated 90% of this data remains unused due to technical glitches.
Founded in 2015 by Georges De Feu and Dries Hens, the Belgian platform is enabling hospitals to unlock this siloed, legacy data to gain insights in the real-world performance of treatments and fuel clinical insights for doctors. The company uses AI and Natural Language Processing (NLP) to improve patient outcome.
The new funding will speed up the international rollout of its platform. Georges De Feu, co-founder and CEO of LynxCare said: “We’re at the forefront of a revolution where neither medical practice nor scientific convention but the actual patients and their data will define the course of healthcare.”
Dr. Christoph Kausch, managing partner at MTIP added: “The timing is perfect to partner with the European health data leader and drive forward the real- world data agenda to enable better healthcare outcomes.”
The Belgian platform has also entered into partnership with PSIH Group, the market leader in clinical business intelligence in France. Through this deal, 66% of French hospital groups can now gain access to LynxCare's software.